YOUR BUSINESS AUTHORITY
Springfield, MO
The U.S. Food and Drug Administration gave the green light for ovarian cancer drug Lynparza to also be used for treatment of pancreatic cancer.
Developers AstraZeneca and Merck say the drug is an advancement in the pharmaceutical industry.
"Patients with advanced pancreatic cancer historically have faced poor outcomes due to the aggressive nature of the disease and limited treatment advances over the last few decades," said Dave Fredrickson, executive vice president of AstraZeneca's oncology business unit, in a statement.
Read more from CBS News.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year